Introduction
Cardiovascular tissues have a prominent load-bearing function. In particular content and organization of collagen fibers in the extracellular matrix contribute to the load-bearing properties and dominate overall tissue strength 1 . In tissue engineering mechanical conditioning of the construct is used -typically consisting of (cyclic) straining regimens -to enhance tissue organization and mechanical properties 2, 3 . Full understanding of strain-induced collagen organization in complex tissue geometries to create tissues with predefined collagen architecture has not yet been achieved. This is mainly due to our limited knowledge of collagen remodeling in developing tissues. Existing models mainly give information about the final net outcome of collagen remodeling with use of static strain [4] [5] [6] . Here we provide a highly tunable model system that allows the study of collagen (re)organization in a real-time fashion, in 3D, under influence of static or cyclic strain. The tissue constructs are fibrin-based, ensuring that all collagen in the construct is endogenous. Cell and collagen organization in the constructs is visualized, and an internal reference system allows us to relocate cells and collagen structures for time-lapse analysis. In this protocol we will describe the use of the model system for Human Vena Saphena Cells (HVSCs), since these cells are known for their enhanced extra cellular matrix production and ability to remodel the matrix and our established use in engineered cardiovascular tissues 7 , based on the work of de Jonge et al. 
Engineering of Fibrin-based Tissue Constructs
1. Prepare silicone glue by mixing the elastomer with the curing agent (10:1). Cut 7 x 3 mm rectangular segments of Velcro. Glue the Velcro into a 6 well culture plate, with flexible membranes to form a cross, and to leave a squared space of 3 mm between the Velcro strips.
Notes: Only use the soft side of the Velcro and face this side upwards. When gluing the Velcro, only cover the Velcro with silicone glue, do not spread glue throughout the well. Since the culture plates have silicone membrane bottoms, use something underneath the well plate for reinforcing the flexible membranes, to ensure easy gluing in to the plate.
2. Dry the silicone glue overnight in an oven at 60 °C to ensure hardening of the glue. Sterilize by adding 70% EtOH to the wells and incubate for 30 min. Rinse 3x with PBS and remove all PBS from the wells and the Velcro. Put under UV for 30 min and keep sterile until use. 3. Prepare Tissue Engineering medium (TM), consisting of GM and 130 mg of L-ascorbic acid 2-phosphate. 4. Add 1 mg/ml ε-Amino Caproic Acid (ACA) to the TM. ACA is used for the first 7 days of culture to prevent the fibrin from degrading 11 . Alternatively, aprotinin can be used. 5. To prevent clump formation, allow fibrinogen to reach room temperature before opening. Without clumps fibrinogen will dissolve more easily.
Dissolve fibrinogen to a concentration of 10 mg actual protein/ml TM 7 supplemented with ACA. Sterile filter the fibrinogen solution, multiple filters might be needed. Store on ice until use.
Note:
To dissolve fibrinogen mix gently to prevent too much foam formation.
6. Dissolve thrombin to a concentration of 10 IU/ml TM 7 supplemented with ACA. Store on ice until use.
Note: Storage on ice is needed to prevent early gelation of thrombin and fibrinogen. 
The fluorescent polystyrene microspheres are used as internal reference markers for image analysis. When mixing thrombin and fibrinogen, prevent the formation of air bubbles by carefully pipetting the mixture. Air bubbles will result in holes in the fibrin gel.
10. Pipette the gel mixture into and in between the Velcro strips. The typical gelation time for the fibrin gels, once the components are mixed, is of the order of 20 sec.
Notes: Do this as quickly as possible to prevent gelation before the mixture is pipetted in the well plate. Practice before using cells and beads.
11. Incubate suspensions for 30 min at 37 °C in a humidified 95% air/5% CO 2 incubator to allow gelation before adding culture TM with ACA. 12. Replace TM with ACA every 2-3 days for the first 7 days. Gels are stable enough after one week to be cultured without ACA. After the first week replace TM every 2-3 days. Add 6 ml of TM per well. On day 12 cells have produced enough collagen for visualization.
Applying Strain and Inducing Changes in Strain and Constraints
1. Static strain is applied by the cells directly, due to cell traction and compaction 12 .
To induce collagen reorganization, cut the tissue construct loose from two Velcro strips in one direction. This results in unidirectional constraints ( Figure 1A) . Perform this on day 12, since the construct is then stable enough and collagen has been deposited. 2. Apply cyclic strain by applying a vacuum to the bottom of the culture plates with flexible membranes, with the use of the Flexcell FX4000T system. Place the plates on a baseplate, on top of loading posts (which are a part of the cyclic loading device). The pump applies a vacuum onto the membrane and thereby pulls the membrane over the rectangular post lying underneath. Due to the cross shaped attachments of the tissue constructs to the membrane (via the Velcro) and the rectangular post the applied cyclic strain is uniaxial (Figure 1B) . 3. Initially, use static culture for 5 days to achieve initial mechanical integrity, before application of cyclic strain starting on day 6. Program a cyclic stain protocol into the controller for the vacuum pump. For example use a previously established intermittent cyclic strain protocol, with uniaxial direction Figure 4 . Representative images after 12 days (5 days static, followed by 7 days cyclic strain) for cyclic strain at the surface (A) and 60 µm into the tissue (B). After a change in cyclic strain direction (after 12 days), at the surface cells and collagen reorient (C) but no changes are seen in the core of the tissue (D) after 3 days.
Discussion
The described model system of cell-populated fibrin constructs has great potential for the study of cell and collagen (re)organization (de Jonge et al. 15 ), e.g. to be used for tissue engineering purposes. By using fibrin as the initial cell carrier, after fibrin degradation, a tissue is created with cells and endogenous matrix only. In this way, cells are stimulated to react to strain, either static or cyclic in nature, by applying contractile forces 16, 17 , sensing boundary stiffness 12 , or displaying strain avoidance.
Significance: Fibrin constructs have been used before to study collagen (re)organization 18 , but not with the ability of applying cyclic strain and/or studying the constructs in a time-lapse manner, both of which are possible in this presented method. The Velcro strips that provide the constraints in this model system have been used before 19 , but combining this technique with culture plates with flexible membranes allows to apply cyclic strain for prolonged periods of time. Culturing in these plates allows for easy addition and removal of medium and visualization of the constructs while still attached and sterile. This enables studying relevant remodeling processes time-lapsed or even real-time.
Modifications and future applications: Future applications of the system can be found in manipulating the 3D remodeling process, for instance by adding metalloproteinases or agents that interfere with integrin assembly or signaling. Next to the application of additives, the components of the model system can be easily modified when studying cell and collagen (re)organization. Different cell sources, healthy and diseased cells, the maturity of the collagen matrix (e.g. by varying culture time), and the shape and size of the construct can be adapted to specific needs. The system is well suited for other cell sources, instead of the currently used HVSCs. We have already used this system to culture endothelial colony forming cells (ECFCs; PlosOne, accepted for publication), where we observe that ECFCs orient their produced collagen differently upon cyclic strain than HVSCs.
Limitations of the technique:
A limitation of the current model system is the relatively large size of the tissues, requiring 1.5 x 10 6 cells per
